Top 10 Penny Stocks Gainers Today - July 21, 2022

As the market extends its surge into the fifth day, the Nifty closed above 16,000 and the Sensex rose nearly 300 points; IndusInd Bank outperforms. 

 On Thursday, the key indices finished with respectable increases. While pharma and health care equities declined, shares of banks, media, and oil and gas companies rose. Due to today's NSE weekly index options expiry, trading was inconsistent. The mood was raised by a change in foreign fund selling in the Indian market.

List of Penny Stocks Today: July 21

Following Table Shows Penny Stocks That Gained Most on July 21

The S&P BSE Sensex increased 284.42 points or 0.51% to 55,681.95, according to the provisional closing basis. To 16,605.25, the Nifty 50 index increased by 84.40 points or 0.51%. Benchmark indexes underperformed the overall market. While the S&P BSE Small-Cap index increased by 0.90%, the S&P BSE Mid-Cap index increased by 1.24%. The market breadth was positive as 2,016 shares rose and 1,325 shares fell. A total of 158 shares were unchanged on the Sensex.

To 28,335.50, the Nifty Pharma index decreased by 0.42%. The index increased 0.23% in the prior trading session. Dr Reddys Laboratories (down 1.95%), Cipla (down 1.43%), Zydus Lifesciences (down 1.13%), and Lupin (down 1.04%) were the top losers among the Nifty Pharma index's constituents.

In anticipation of the European Central Bank's most recent monetary policy announcement, in which it is widely anticipated to announce its first interest rate hike in years, investors sold down the majority of European stocks on Thursday. After the Bank of Japan kept interest rates unchanged, Asian stocks had a mixed day on Thursday. As anticipated, the Bank of Japan maintained its ultra-easy monetary policy while reducing its 2022 growth projection and upping its inflation forecasts.

With an eye on inflation and potential future interest rate hikes from the Fed, US markets ended the day higher on Wednesday. At its meeting next week, the US Federal Reserve will decide against making a larger change in order to combat persistently rising inflation as the likelihood of a recession over the coming year climbs to 40%, according to reports.